Table 4 Comparisons of laboratory parameters between drug groups at baseline or at the time of critical values.
| Ā | Vancomycin (nā=ā99) | Digoxin (nā=ā25) | Tacrolimus (nā=ā35) | PĀ value # |
|---|---|---|---|---|
WBC (Ćā109/L) | ||||
Ā Baseline | 9.600 (0.7ā44.3) | 7.2 (4.2ā35.2) | 6.5 (1.3ā21.8) | 0.289 |
Ā Critical value | 8.600 (1.2ā38.6) | 11.1 (5.6ā22.1) | 8.0 (0.7ā19.4) | 0.818 |
N (%) | ||||
Ā Baseline | 80.7 (24ā97.2) | 79.5 (62ā92.4) | 70.2 (28.9ā98.4) | 0.082 |
Ā Critical value | 81.9 (42.6ā95.7) | 82.5 (65.7ā91.8) | 88.6 (43.5ā96.9) | 0.371 |
L (%) | ||||
Ā Baseline | 12.50 (1.1ā51.9) | 12.2 (1.2ā29.8) | 16.6 (0.7ā62.6) | 0.033* |
Ā Critical value | 10.10 (1ā41.1) | 10.4 (3.2ā22.3) | 8.25 (0.5ā2.6) | 0.711 |
Hb (g/L) | ||||
Ā Baseline | 106.0 (25ā192) | 106.0 (71ā204) | 98.0 (45ā147) | 0.371 |
Ā Critical value | 82.0 (47ā140) | 79.0 (55ā174) | 84.0 (42ā135) | 0.207 |
PLT (Ćā1012/L) | ||||
Ā Baseline | 174.0 (23ā614) | 170.0 (73ā898) | 211.0 (18ā526) | 0.579 |
Ā Critical value | 166.0 (2ā565) | 140.0 (47ā1120) | 126.0 (12ā508) | 0.455 |
TB (mg/L) | ||||
Ā Baseline | 14.6 (3.3ā405.8) | 17.4 (8.7ā91.8) | 13.1 (4.1ā373.4) | 0.576 |
Ā Critical value | 18.6 (11.3ā540.6) | 31.3 (9.4ā276.8) | 15.5 (4.2ā368.2) | 0.894 |
TP (g/dL) | ||||
Ā Baseline | 63.15 (26.3ā88.6) | 63.30 (48.2ā43.7) | 61.1 (40.3ā79.9) | 0.932 |
Ā Critical value | 59.8 (28.9ā79.1) | 60.9 (47.6ā73.5) | 62.2 (30.3ā70.1) | 0.529 |
ALB (g/dL) | ||||
Ā Baseline | 32.50 (14ā49.7) | 32.70 (24.2ā42.9) | 33.35 (22.0ā42.8) | 0.795 |
Ā Critical value | 32.95 (16.4ā47.2) | 33.00 (28.1ā38.8) | 35.2 (18.6ā44.7) | 0.742 |
ALT (IU/L) | ||||
Ā Baseline | 29.00 (3ā2230) | 22.00 (3ā106) | 31.00 (9ā1497) | 0.614 |
Ā Critical value | 34.0 (1ā1982) | 26.5 (8ā209) | 32.0 (9ā595) | 0.609 |
AST (IU/L) | ||||
Ā Baseline | 29.00 (5ā4480) | 37.00 (8ā474) | 36.00 (13ā1802) | 0.844 |
Ā Critical value | 41.0 (9ā2280) | 43.0 (19ā305) | 38.0 (13ā787) | 0.748 |
BUN | ||||
Ā Baseline | 6.820 (1.3ā59.6) | 10.82 (4.3ā33.1) | 8.2 (1.3ā17.7) | 0.072 |
Ā Critical value | 8.54 (1.4ā36.9) | 18.22 (7.6ā35.3) | 10.65 (2.7ā34.1) | 0.002 |
Cr | ||||
Ā Baseline | 75.00 (10ā1476) | 161.0 (38ā850) | 84.5 (15ā780) | 0.446 |
Ā Critical value | 81.5 (5ā805) | 161.5 (75ā785) | 87.5 (12ā540) | 0.007 |
CRP | ||||
Ā Baseline | 48.76 (0.7ā314.6) | 14.6 (4ā252.1) | 11.5 (1.6ā208.) | 0.144 |
Ā Critical value | 55.65 (4.4ā293.3) | 47.0 (5.5ā126) | 49.50 (5.3ā34.9) | 0.256 |
PCT | ||||
Ā Baseline | 0.5 (0ā88.2) | 0.4 (0.1ā58.0) | 0.2 (0ā78.4) | 0.993 |
Ā Critical value | 1.450 (0.1ā93.1) | 2.97 (0.2ā19.4) | 1.170 (0.1ā75.2) | 0.856 |
NTproBNP | ||||
Ā Baseline | 1477 (32ā20,518) | 12,577 (466ā35,000) | 1923 (15ā17,022) | <ā0.001* |
Ā Critical value | 2104 (27ā50,852) | 11,824 (4927ā35,000) | 3780 (206ā34,475) | 0.005* |